Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy

  • Domenico Catanzariti
  • Massimiliano Maines
  • Giuseppe Vergara
Conference paper


Early studies suggested that hypertrophic cardiomyopathy (HCM), an inherited and primary disease of cardiac muscle characterized by a thickening of the left ventricular (LV) walls, was a relatively uncommon but malignant disorder. The annual mortality rates were reported to be 2–4% in adults and 6% in adolescents and children, the majority of deaths being sudden. Recently it has been found that HCM is, in fact, more common than originally assumed, with a prevalence estimated from echocardiographic population screening of 0.2%. It is also now clear that HCM is much more benign, with an annual mortality rate in large unselected non-referred series of approximately 1.5%. More than half of these deaths are sudden while the remainder are largely caused by heart failure and stroke [1]–[3]. This relatively low incidence creates a challenge for risk stratification. Furthermore, most individuals with HCM are asymptomatic and the first manifestation may be sudden cardiac death (SCD), related to ventricular arrhythmia with potential triggers including ischemia, outflow obstruction, and atrial fibrillation.


Sudden Cardiac Death Hypertrophic Cardiomyopathy Left Ventricular Outflow Tract Obstruction Ventricular Tachycardia Sudden Cardiac Death Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775–785PubMedCrossRefGoogle Scholar
  2. 2.
    Maron BJ 2002) Hypertrophic cardiomyopathy. A systematic review. JAMA 287:1308–1320PubMedCrossRefGoogle Scholar
  3. 3.
    Elliott P, McKenna WJ (2004) Hypertrophic cardiomyopathy. Lancet 363:1881–1891PubMedCrossRefGoogle Scholar
  4. 4.
    Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713PubMedCrossRefGoogle Scholar
  5. 5.
    Olivotto I, Cecchi F, Casey SA et al (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524PubMedCrossRefGoogle Scholar
  6. 6.
    Maron MS, Olivotto I, Betocchi S et al (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348:295–303PubMedCrossRefGoogle Scholar
  7. 7.
    AIAC (2005) Linee guida all’impianto di PM e ICD. Giornale Italiando di Aritmologia e Cardiostimolazione 8(4):54–66; available at: www.aiac.itGoogle Scholar
  8. 8.
    Maron BJ, Shen WK, Link MS et al (2000) Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342:365–373PubMedCrossRefGoogle Scholar
  9. 9.
    Spirito P, Bellone P, Harris KM et al (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342:1778–1785PubMedCrossRefGoogle Scholar
  10. 10.
    Elliott PM, Poloniecki J, Dickie S et al (2000) Sudden death in hypertrophic cardiomopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218PubMedCrossRefGoogle Scholar
  11. 11.
    Monserrat L, Elliott PM, Gimeno JR et al (2003) Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 42:873–879PubMedCrossRefGoogle Scholar
  12. 12.
    Spirito P, Autore C (2006) Management of hypertrophic cardiomyopathy. BMJ 332:1251–1255PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Domenico Catanzariti
    • 1
  • Massimiliano Maines
    • 1
  • Giuseppe Vergara
    • 1
  1. 1.Cardiology DivisionS. Maria del Carmine HospitalRovereto (TN)Italy

Personalised recommendations